Work

Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease

Year: 2014

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2014.01.037

Authors: David A. Bennett, Lei Yu, Philip L. De Jager

Institutions: Rush University Medical Center, Broad Institute, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Illinois Department of Public Health, National Institutes of Health, National Institute on Aging

Awards: Epidemiologic Study of Neural Reserve and Neurobiology of Aging, Genetic Epidemiology of Cognitive Decline in an Aging Population Sample, Exploring the Role of the Brain Transcriptome in Cognitive Decline, Pathway discovery, validation and compound identification for Alzheimer's disease, Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences, Risk Factors, Pathology, and Clinical Expressions of AD, Rush Alzheimer's Disease Core Center, Alzheimer's Disease Genetics Consortium, Cognitive Decline and Dementia: Life Experiences and the Brain Histone Epigenome, Exploring the Role of the Brain Epigenome: Cognitive Decline and Life Experiences

OpenAlex ID: W2089216251

FWCI: 3.765

Cites: 210

Cited by: 57

Related to: 10